As the consultation period draws to a close for the UK’s new inclusion and diversity guidance, researchers and sponsors are being invited to participate in a pilot next year to submit a diversity plan as part of their clinical trial application.
The UK’s draft guidance on how study sponsors should go about preparing an inclusion and diversity plan as part of their clinical trial application for the research ethics committees (RECs) has already drawn over 200 comments from stakeholders.
The draft guideline was issued for an informal consultation in October and remains open for feedback until 9 December
Israeli-based SpotitEarly hopes to bring an early cancer-detection test, which uses dogs’ noses to detect compounds in exhaled breath and AI analysis, to US homes in 2026.
King’s College London, Imperial College London and The Alan Turing Institute constructed cardiac digital twins at scale, creating over 3,400, in a new study using UK Biobank data published in Nature Cardiovascular Research on 16 May.
Apart from the reimbursement-driven turbulence in diagnostics, other aspects of Danaher’s China business are showing signs of resilience. Patient volumes remain strong and the company does not see evidence that the Chinese government is attempting to actively push Western suppliers out of its healthcare system.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
